![(1AR,5S,8S,10R,22AR)-5-(叔丁基)-1,1A,3,4,5,6,9,10,18,19,20,21,22,22A-十四氢-14-甲氧基-3,6-二氧代-8H-7,10-甲桥环丙烯并[18,19][1,10,3,6]二氧杂二氮杂环十九碳九烯并[11,12-B]喹喔啉-8-羧酸甲酯](https://china.chemnet.com/product/images/no.jpg)
(1AR,5S,8S,10R,22AR)-5-(叔丁基)-1,1A,3,4,5,6,9,10,18,19,20,21,22,22A-十四氢-14-甲氧基-3,6-二氧代-8H-7,10-甲桥环丙烯并[18,19][1,10,3,6]二氧杂二氮杂环十九碳九烯并[11,12-B]喹喔啉-8-羧酸甲酯
产品类别:
中间体/医药中间体英文名称:
8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-diMethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-Methoxy-3,6-dioxo-, Methyl ester, (1aR,5S,8S,10R,22aR)-CAS NO:
1206524-84-6分 子 量:
暂无数据EC NO:
暂无数据规 格:
暂无数据包 装:
暂无数据结 构 式:
暂无数据
暂无产品详细介绍
| 品名: | (1AR,5S,8S,10R,22AR)-5-(叔丁基)-1,1A,3,4,5,6,9,10,18,19,20,21,22,22A-十四氢-14-甲氧基-3,6-二氧代-8H-7,10-甲桥环丙烯并[18,19][1,10,3,6]二氧杂二氮杂环十九碳九烯并[11,12-B]喹喔啉-8-羧酸甲酯 |
|---|---|
| 用途: | 暂无数据 |
| 别名 | (1AR,5S,8S,10R,22AR)-5-(叔丁基)-1,1A,3,4,5,6,9,10,18,19,20,21,22,22A-十四氢-14-甲氧基-3,6-二氧代-8H-7,10-甲桥环丙烯并[18,19][1,10,3,6]二氧杂二氮杂环十九碳九烯并[11,12-B]喹喔啉-8-羧酸甲酯 |